EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

CDSCO Approves Wegovy and Poviztra for Fatty Liver Treatment - The Central Drugs Standard Control Organisation (CDSCO) has approved two new treatment options for metabolic dysfunction-associated steatohepatitis (MASH), commonly known as fatty liver disease, marking a significant advancement in India’s fight against a growing liver health crisis. Novo Nordisk’s Wegovy (semaglutide) and Emcure Pharmaceuticals’ Poviztra have received regulatory clearance for this indication, as reported by […]
Trump’s Phased Generic Drug Tariff Targets India’s $9.7B Exports - On July 21-22, 2026, President Donald Trump unveiled a phased tariff plan on imported generic drugs, targeting the reshoring of pharmaceutical manufacturing to the United States. The announcement sent shockwaves through India’s pharmaceutical sector, which supplies approximately 40% of America’s generic drug prescriptions and exports $9.7 billion in generic medicines to the US annually. The […]
Iran War and Hormuz Crisis Reshape Global Pharma Supply Chains - The ongoing Iran war and the disruption of shipping through the Strait of Hormuz have triggered one of the most significant shocks to global pharmaceutical supply chains in decades. For international buyers of Indian generic medicines, understanding how this geopolitical crisis affects drug availability, pricing, and supply reliability has become essential for informed sourcing decisions […]
Sun Pharma Wins South Africa Approval for Generic Semaglutide - Sun Pharmaceutical Industries, India’s largest drugmaker, has received approval from the South African Health Products Regulatory Authority (SAHPRA) to market a generic version of semaglutide injection. The approval marks a significant expansion of Indian generic GLP-1 drugs into Africa’s largest pharmaceutical market, following the expiry of Novo Nordisk’s patent protections in key global markets. Reported […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us